FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

900000000000526001: REPLACED BY association reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001156010 REPLACED BY association reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001157018 REPLACED BY association reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


23369 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
REPLACED BY association reference set (foundation metadata concept) Is a Historical association reference set (foundation metadata concept) true Inferred relationship Some

Members targetComponentId
Mental handicap Intellectual disability
Mental handicap (specialty) Intellectual disability specialty
Mental handicap (specialty) Intellectual disability specialty
Mental handicap (specialty) Intellectual disability specialty
Mental handicap psychiatry department Intellectual disability psychiatry department (environment)
Mental handicap psychiatry service Intellectual disability psychiatry service
Mental health annual physical examination done Annual physical examination for people with mental illness completed
Mental health crisis plan Mental health crisis plan
Mental health personal health plan Mental health personal health plan
Mental retardation Intellectual disability
Mental retardation NOS Intellectual disability
Mental retardation NOS Intellectual disability
Mental retardation NOS Intellectual disability
Mental retardation screening Intellectual disability screening
Mental/developmental handicap screening Screening for developmental disorder (procedure)
Mental/developmental handicap screening NOS Screening for developmental disorder (procedure)
Mental/developmental handicap screening NOS Screening for developmental disorder (procedure)
Menthol 35.55mg inhalant capsule Product containing only menthol in pulmonary dose form (medicinal product form)
Mepacrine hydrochloride 100mg tablet Mepacrine hydrochloride 100 mg oral tablet
Meperidine hydrochloride 100mg/mL injection solution ampule Product containing only pethidine in parenteral dose form (medicinal product form)
Meperidine hydrochloride 50mg/5mL syrup Pethidine hydrochloride 10 mg/mL oral solution
Meperidine hydrochloride 50mg/mL injection solution ampule Product containing only pethidine in parenteral dose form (medicinal product form)
Meperidine hydrochloride 50mg/promethazine hydrochloride 50mg injection solution vial Product containing only pethidine and promethazine (medicinal product)
Mepivacaine hydrochloride 3%/levonordefrin 1:20,000 injection solution vial Corbadrine 50 microgram/mL and mepivacaine hydrochloride 30 mg/mL solution for injection
Mepivacaine hydrochloride 30mg/sodium chloride 3mg injection solution vial Mepivacaine only product
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection
Mepivacaine hydrochloride+epinephrine 2%/1:100,000 cartridge Adrenaline 10 microgram/mL and mepivacaine hydrochloride 20 mg/mL solution for injection
Meptazinol 100mg/1mL injection Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Meptazinol 100mg/mL injection solution 1mL ampule Product containing precisely meptazinol (as meptazinol hydrochloride) 100 milligram/1 milliliter conventional release solution for injection (clinical drug)
Meptazinol 200mg tablet Meptazinol (as meptazinol hydrochloride) 200 mg oral tablet
Mercurophylline injection Mercurophylline
Merselene patch Polyester mesh (physical object)
Mesalamine 250mg capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 250mg m/r capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 250mg prolonged-release oral capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 375mg m/r capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalamine 375mg prolonged-release oral capsule Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine 1g/100mL retention enema Mesalazine only product in rectal dose form
Mesalazine 1g/100mL retention enema Mesalazine only product in rectal dose form
Mesalazine 2g/59mL enema Mesalazine only product in rectal dose form
Mesalazine 500mg/sachet gastro-resistant and prolonged-release oral granules Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine 500mg/sachet m/r granules Product containing only mesalazine in oral dose form (medicinal product form)
Mesalazine duplicate deleted Product containing mesalazine (medicinal product)
Mesenteric venous thrombosis Thrombosis of mesenteric vein
Mesio-occlusion Mesio-occlusion of teeth
Mesonephric tumor Wolffian tumor of uncertain behavior (morphologic abnormality)
Mesoridazine besylate 10mg/mL injection solution ampule Product containing precisely mesoridazine 10 milligram/1 milliliter conventional release solution for injection (clinical drug)
Mesoridazine besylate 25mg/mL injection solution ampule Product containing precisely mesoridazine 25 milligram/1 milliliter conventional release solution for injection (clinical drug)
Mesothelioma, biphasic, benign Mesothelioma, benign
Metabolic acidosis caused by ingestion of drugs AND/OR chemicals Metabolic acidosis
Metabolic disease, NEC Metabolic disease
Metabolic function test NOS Metabolic function test
Metabolic function test NOS Metabolic function test
Metabolic marker Inborn errors of metabolism marker
Metabolic monitoring NOS Metabolic monitoring procedure
Metabolic monitoring NOS Metabolic monitoring procedure
Metacarpal X-ray Plain X-ray of metacarpal bone
Metacarpal X-ray Plain X-ray of metacarpal bone
Metacarpal X-ray Plain X-ray of metacarpal bone
Metaiodobenzylguanidine[123I] 74MBq/mL injection Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[123I] 74MBq/mL powder for injection solution vial Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I] 37MBq/mL injection Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I] 37MBq/mL powder for injection solution vial Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I]370MBq/mL injection Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I]37MBq/mL diagnostic injection Iobenguane (131-I)-containing product in parenteral dose form
Metaiodobenzylguanidine[131I]9.25MBq/mL diagnostic injection Iobenguane (131-I)-containing product in parenteral dose form
Metal engineering machiner NOS Engineering machiner (occupation)
Metal engineering machiner NOS Engineering machiner (occupation)
Metal processor/treater NOS Metal processer
Metal processor/treater NOS Metal processer
Metal production fitter NOS Metal production fitter
Metal production fitter NOS Metal production fitter
Metal/electrical worker NOS Metal/electrical worker (occupation)
Metal/electrical worker NOS Metal/electrical worker (occupation)
Metallocarboxypeptidase Metallocarboxypeptidase
Metalloproteinase Metalloproteinase (substance)
Metaproterenol 20mg tablet Orciprenaline sulfate 20 mg oral tablet
Metaproterenol sulfate 0.65mg/inh aerosol Orciprenaline only product in pulmonary dose form
Metaproterenol sulfate 15mg/mL aerosol Product containing precisely orciprenaline sulfate 15 milligram/1 milliliter conventional release solution for inhalation (clinical drug)
Metastasis stage M1a American Joint Committee on Cancer cM1a (qualifier value)
Metastasis stage M1b American Joint Committee on Cancer cM1b (qualifier value)
Metastasis stage M1c American Joint Committee on Cancer cM1c (qualifier value)
Metastasis stage M2 American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage M3 American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage M4 American Joint Committee on Cancer cM1 (qualifier value)
Metastasis stage pM1 American Joint Committee on Cancer pM1 (qualifier value)
Metastasizing pleomorphic adenoma Pleomorphic adenoma
Metastatic apocrine adenocarcinoma to skin Metastatic apocrine adenocarcinoma (disorder)
Metastatic carcinoid tumor Metastatic well-differentiated neuroendocrine tumor (disorder)
Metastatic carcinoid tumor Metastatic well-differentiated neuroendocrine tumor (morphologic abnormality)
Metastatic carcinoma to female breast Metastatic carcinoma to breast
Metastatic carcinoma to male breast Metastatic carcinoma to breast
Metastatic cholangiocarcinoma to biliary tract Metastatic cholangiocarcinoma (morphologic abnormality)
Metastatic cholangiocarcinoma to perihilar bile duct Metastatic cholangiocarcinoma
Metastatic collecting duct carcinoma to kidney Metastatic collecting duct renal cell carcinoma (disorder)
Metastatic cystic renal cell carcinoma to kidney Metastatic cystic renal cell carcinoma
Metastatic eccrine porocarcinoma to skin Metastatic eccrine porocarcinoma
Metastatic infiltrating duct carcinoma to female breast Metastatic infiltrating duct carcinoma to breast (disorder)
Metastatic lobular carcinoma to breast Metastatic lobular carcinoma (disorder)
Metastatic lobular carcinoma to left female breast Metastatic lobular carcinoma (disorder)
Metastatic lobular carcinoma to right female breast Metastatic lobular carcinoma (disorder)

Start Previous Page 114 of 234 Next End


Reference Sets

Reference set descriptor

Back to Start